About Myka Labs

Myka Labs was founded with the goal of leveraging artificial intelligence and advanced sensor systems for high-clinical-impact procedures in the abdomen. Central to the company's founding: pioneering research carried out at the University of California at San Francisco and a LMU Klinikum in Germany on new ways of repairing congenital malformations involving the esophagus and the windpipe. This pioneering research effort, led by Myka Labs founder Dr. Michael Harrison and LMU Klinikum's Dr. Oliver Muensterer, paved the way for a paradigm shift in how pediatric surgeons approach the repair of these birth defects. The research held out hope that, for the first time, patients would be able to undergo repairs that would condition the repaired tissue for long-term health, while also avoiding a highly invasive surgery. Every year around the world, some 25,000 newborns are born with tracheoesophageal birth defects requiring surgical repair.

Early Myka Labs artificial intelligence models for real-time surgical team awareness, along with the first Myka Labs multifunctional sensorized catheters, are developed and transitioned into preclinical studies, with astoundingly favorable results. At the same time, Connect-EA is successfully used in repairing tracheoesophageal birth defects at Stanford, Vanderbilt and LMU Klinikum.

Multiple publications in leading pediatric surgery journals report on the successful use of Connect-EA for repair of birth defects affecting the windpipe and esophagus. Multiple Myka Labs patents issue. Myka Labs expands its core team and advisory board, adding top specialists from around the world.